MOVIVA®: A Game-Changing, Non-Surgical Weight Loss Innovation Now Available in the UAE

In terms of managing obesity, Dubai is setting a new standard. Medcare Royal Speciality Hospital, part of Aster DM Healthcare, has debuted Moviva, the UAE's first non-surgical, medicine-free endoscopic weight-loss technique, marking a major milestone in minimally invasive bariatric care. It is now the first hospital in the Middle East to provide this innovative German-engineered equipment.

For patients seeking effective weight loss without surgery, injections, or long-term medication, Moviva is a potent new alternative now accessible abroad through MediGence, a trusted global medical tourism network.

What Is Moviva and Why Is It Different?

Unlike traditional bariatric surgery, which permanently reduces stomach size, Moviva targets the biological root of hunger.

The procedure focuses on ghrelin, the hormone that regulates hunger. Ghrelin is primarily produced in the fundus, the upper part of the stomach. By treating this specific area through a minimally invasive endoscopic technique, Moviva helps patients:

• Feel full sooner
• Eat less naturally
• Reduce cravings
• Achieve sustainable weight loss driven by biology, not deprivation
• Most importantly, the procedure is:
• Incision-free
• Scar-free
• Same-day
• Medication-free

Performed entirely through the mouth

The Science Behind Moviva

Moviva is a minimally invasive, non-surgical weight-loss innovation designed to help patients manage hunger naturally from within the stomach.
The procedure works by performing Gastric Mucosal Ablation (GMA) on the gastric fundus, the upper part of the stomach where ghrelin, the hormone responsible for hunger, is produced.

Key benefits of Moviva include:

• Reduces ghrelin levels, helping control appetite
• Subtly shrinks the fundus to support portion control
• Helps patients feel fuller and curb cravings naturally
• Promotes sustainable weight loss without surgery, injections, or medication
• The Moviva probe enables precise, safe, and consistent treatment by combining:
• Needle-free submucosal fluid injection
• Superficial thermal ablation using argon plasma coagulation (APC)
• GMA can be performed:
• As a stand-alone procedure

Or alongside Endoscopic Sleeve Gastroplasty (ESG), achieving weight-loss results comparable to surgical sleeve gastrectomy, while remaining less invasive and organ-preserving

With growing clinical adoption worldwide, Moviva marks a new era in hormone-focused, minimally invasive bariatric care, offering patients an effective, science-driven path to long-term weight management.

Expert Insight from a Top Gastroenterologist

The Moviva procedure at Medcare Royal Speciality Hospital is led by Prof. Dr Mohamed Abdelhafez, one of the most respected and experienced top gastroenterologists in the UAE.
Formerly the Head of Endoscopy at the Technical University of Munich, Prof. Dr Abdelhafez has performed over 30,000 endoscopic procedures and explains the philosophy behind Moviva: "Hunger is not merely a lack of willpower; it is influenced by hormones. With this technology, we are not shrinking the stomach; we are lowering the volume of hunger itself."
This hormone-focused approach explains why many patients struggle with long-term weight loss despite dietingand why Moviva offers a more sustainable solution.

Early Results and Expected Outcomes

The results doctors are seeing at Medcare Royal Speciality Hospital are encouraging so far. This is good news for the people who go there for help.

• Some patients have already lost around 10% of their body weight. This is a loss of body weight for these patients.
• When people use this alongside doctor-supervised treatments, they can lose significant weight. Some patients may lose up to 27 per cent of their body weight. This is a deal for people who want to lose weight. Weight reduction is a goal for many people, and this can significantly help with it.

Moviva effectively bridges the gap between dieting and bariatric surgery. This makes Moviva a great choice for patients who:

• Have experienced repeated diet failures
• Are not suitable candidates for surgery
• Prefer a safer, less invasive option

Exclusively Available at Medcare - Part of Aster DM Healthcare

Medcare Royal Speciality Hospital in the United Arab Emirates offers Moviva. which is highly skilled in endoscopy and minimally invasive medicine. Medcare operates under Aster DM Healthcare, one of the most trusted healthcare groups in the region. They are known for things such as:

• JCI-accredited hospitals
• State-of-the-art infrastructure
• Multidisciplinary, patient-centred care

The hospital's comprehensive weight-management program integrates:

• Expert gastroenterology care
• Nutritional counselling
• Lifestyle modification
• Long-term follow-up

Moviva Cost and Packages

This advanced, non-surgical weight-loss treatment is now available to patients at transparent and competitive costs:

• Moviva only: USD 8,168.82
• Moviva with suturing: USD 16,337.65
  

Through MediGence, international patients can conveniently access this treatment at Medcare, part of the Aster DM Healthcare group, and benefit from top gastroenterologists, globally accredited facilities, and comprehensive support throughout their medical journey.

Access Moviva Through MediGence

Patients from other countries can now access Moviva at Medcare Royal Speciality Hospital through MediGence. This makes it really easy for international patients to travel for care. Moviva at Medcare Royal Speciality Hospital is a destination for international patients seeking the care they need.

Through MediGence, patients benefit from:

• Access to top gastroenterologists and advanced endoscopic care
• Treatment at globally accredited hospitals
• End-to-end support, including consultations, treatment planning, and travel coordination

The Future of Weight Loss Is Here

As Prof. Dr Abdelhafez highlights:

"Advanced endoscopy is shaping the future of medicine. We are moving away from invasive surgery toward precision-based, organ-preserving treatments that deliver effective results with fewer risks and faster recovery."

Through MediGence, patients worldwide can now access this breakthrough innovationexclusively at Medcare Royal Speciality Hospital, part of Aster DM Healthcare.